Yimutian Inc. (YMT)
Yimutian will go public soon, but the exact IPO date is still unknown.
IPO Price Range
$4.10 - $5.00
Shares Offered
5,010,000
Deal Size
$22.80M
Sage Therapeutics Revenue
In the year 2024, Yimutian had annual revenue of 161.32M CNY, down -13.97%.
Revenue (ttm)
161.32M CNY
Revenue Growth
-13.97%
P/S Ratio
23.19
Revenue / Employee
245,542 CNY
Employees
657
Market Cap
520.42M USD
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 161.32M | -26.20M | -13.97% |
| Dec 31, 2023 | 187.52M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionYMT News
- 10 days ago - IPO Candidate Yimutian Seeks Inflated Valuation On Falling Revenue - Seeking Alpha
- 2 months ago - Chinese agricultural B2B platform Yimutian files for a $40 million US IPO - Renaissance Capital
- 2 months ago - Yimutian IPO Registration Document (F-1) - SEC